← Leaderboards
Dwayne G Stupack
University Of California San Diego
$7,282,267
Attributed
$10,565,374
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,565,374 · 5
By mechanism
R01$7,200,766 · 3
T32$2,487,118 · 1
P50$877,490 · 1
Top collaborators
- David D Schlaepfer5 shared
- Shunichi Shimasaki5 shared
- Michael Bouvet4 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- Shunichi Shimasaki$7,451,712
- Pamela L Mellon$36,611,301
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticIn VitroMalignant NeoplasmsTumorCellsMolecularIn VivoIntegrinsCessation Of LifeTumor GrowthPre-Clinical ModelGenesSignal TransductionMapsComplexChemotherapyLinkSiteNeoplasm MetastasisMediatingResistanceBirdsAdhesionsCell Motility
Grant awards (32)
UCSD Cancer Center Training Program in Drug Development$510,659
T32 · FY2025 · CA
UCSD Cancer Center Training Program in Drug Development$660,886
T32 · FY2024 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer$446,456
R01 · FY2024 · CA
FOXL2 in Adult Granulosa Cell Tumorigenesis$343,355
R01 · FY2024 · CA
UCSD Cancer Center Training Program in Drug Development$678,502
T32 · FY2023 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer$460,555
R01 · FY2023 · CA
FOXL2 in Adult Granulosa Cell Tumorigenesis$354,197
R01 · FY2023 · CA
UCSD Cancer Center Training Program in Drug Development$637,071
T32 · FY2022 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer$460,555
R01 · FY2022 · CA
FOXL2 in Adult Granulosa Cell Tumorigenesis$354,197
R01 · FY2022 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer$469,705
R01 · FY2021 · CA
FOXL2 in Adult Granulosa Cell Tumorigenesis$361,330
R01 · FY2021 · CA
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer$468,466
R01 · FY2020 · CA
FOXL2 in Adult Granulosa Cell Tumorigenesis$360,281
R01 · FY2020 · CA
Integrins and Caspase 8 in Tumor Progression$292,196
R01 · FY2014 · CA · contact PI
Integrins and Caspase 8 in Tumor Progression$25,939
R01 · FY2014 · CA · contact PI
Integrins and Caspase 8 in Tumor Progression$283,159
R01 · FY2013 · CA · contact PI
Integrins and Caspase 8 in Tumor Progression$61,172
R01 · FY2013 · CA · contact PI
Integrins and Caspase 8 in Tumor Progression$300,934
R01 · FY2012 · CA · contact PI
Targeted Smart Nanoplatforms for Multimode Imaging$147,174
P50 · FY2012 · CA · contact PI
Integrins and Caspase 8 in Tumor Progression$300,044
R01 · FY2011 · CA · contact PI
Targeted Smart Nanoplatforms for Multimode Imaging$158,157
P50 · FY2011 · CA · contact PI
Integrins and Caspase 8 in Tumor Progression$309,323
R01 · FY2010 · CA · contact PI
Targeted Smart Nanoplatforms for Multimode Imaging$230,032
P50 · FY2010 · CA · contact PI
Integrins and Caspase 8 in Neuroblastoma Progression$300,314
R01 · FY2009 · CA · contact PI
Targeted Smart Nanoplatforms for Multimode Imaging$208,638
P50 · FY2009 · CA · contact PI
Integrins and Caspase 8 in Neuroblastoma Progression$300,314
R01 · FY2008 · CA · contact PI
Targeted Smart Nanoplatforms for Multimode Imaging$133,489
P50 · FY2008 · CA · contact PI
Integrins and Caspase 8 in Neuroblastoma Progression$300,314
R01 · FY2007 · CA · contact PI
Integrins and Caspase 8 in Neuroblastoma Progression$308,698
R01 · FY2006 · CA · contact PI
Integrins and Caspase 8 in Neuroblastoma Progression$200,865
R01 · FY2005 · CA
Integrins and Caspase 8 in Neuroblastoma Progression$138,397
R01 · FY2005 · CA